Judi Ramiscal

The role of LAT1 in 18F-DOPA uptake in malignant gliomas

Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson et al. · Journal of Neuro-Oncology · 2012 · 144 citations

Medicine, Oncology, Pharmacology +11

Identification of Preferred Chemotherapeutics for Combining with a <i>CHK1</i> Inhibitor

Judi Ramiscal, Kaska Kowanetz, Christopher Del Nagro et al. · Molecular Cancer Therapeutics · 2013 · 58 citations · Full text

Medicine, Oncology, Pharmacology +16

Combination Drug Scheduling Defines a “Window of Opportunity” for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900

Elizabeth Blackwood, Jennifer Epler, Ivana Yen et al. · Molecular Cancer Therapeutics · 2013 · 37 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Bevacizumab-induced nasal septal perforation: Incidence of symptomatic, confirmed event(s) in colorectal cancer patients

Judi Ramiscal, Aminah Jatoi · Acta Oncologica · 2010 · 22 citations · Full text

Medicine, Oncology, Otolaryngology +5

Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1

Lewis Gazzard, Karen Williams, Huifen Chen et al. · Journal of Medicinal Chemistry · 2015 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17